Speaker illustration

Doctor Philippe Rouet

Rangueil Hospital of Toulouse, Toulouse (France)

sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure, independent of Mineralocorticoid Receptor Antagonists treatment.

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

This platform is supported by

logo Novo Nordisk